Implementation of the Intravitreal Injection Administered by Nurses
NCT06511700 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-03-24
Summary
Introduction:
Intravitreal injections involve medication administration into the eye to treat ocular diseases and protect vision. Through an injection, the medication is introduced into the vitreous cavity, an area located at the back of the eye, behind the lens. The intravitreal injection (IVI) is a minimally invasive process administered at personalized regular intervals. It is a common procedure in ophthalmology for patients who require it. International experiences demonstrate that administering intravitreal injections, especially by nurses trained in aseptic techniques, is feasible without compromising patient safety. The project presented is based on a new care model rooted in interdisciplinary collaboration in the IVI process, operationalizing it as a functional unit. This is a great opportunity to expand the scope of practice for nurses and to demonstrate, as has been done in other countries, that the same procedure currently performed by ophthalmologists can be carried out with equal safety.
Objective:
To evaluate the safety of implementing a program incorporating nurses trained in administering intravitreal injections within the functional unit of Ophthalmology at Corporation Parc Tauli.
Method:
Observational evaluation study of a care process within the functional Ophthalmology Unit, consisting of protocol application for intravitreal injection by trained nurses. Data will be collected from users receiving care from the intravitreal injection service administered by nurses under a consensual procedure within the unit. Users meeting the inclusion criteria will be eligible. Nurses will be trained internally at CCSPT by the ophthalmology team. User participation will be voluntary. Informed consent will be obtained. Data collection during the process of care will include recording selected variables. Data collection will be carried out between 2024 and 2025. The study will be conducted over 3 years.
Application and Impact:
The development of this project will allow for a safe, more efficient redistribution of our resources. The functional unit is based on a group of professionals who work and make decisions jointly. The new distribution will enable ophthalmologists to expand their availability for more complex procedures. In the future, it is expected to increase the number of users who can benefit from the IVI service and to initiate advanced competencies in the role of the ophthalmology nurse.
Conditions
- Macular Edema
- Macular Degeneration
- Diabetic Macular Edema
Interventions
- PROCEDURE
-
It is a implementation a program incorporating nurses trained in administering intravitreal injections within the functional unit of Ophthalmology following the usual technique
Internationally, some experiences demonstrate that the administration of intravitreal injections, especially by nurses trained in aseptic techniques, is feasible without compromising patient safety. Although there is already some experience in Spain, it is a new procedure within the nursing field of the Ophthalmology service for which no results have been reported.
Sponsors & Collaborators
-
Corporacion Parc Tauli
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-15
- Primary Completion
- 2025-12-30
- Completion
- 2026-06-30
Countries
- Spain
Study Locations
More Related Trials
-
Intravitreal Conbercept After Vitrectomy
NCT03426540 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema, Retinal Vein Occlusion and Myopic Choroidal Neovascularisation Patients
NCT06879301 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy in Patients With Types 1 and 2 Diabetes Mellitus
NCT00287651 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection
NCT02933905 ·Status: COMPLETED
-
Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy
NCT06713720 ·Status: RECRUITING ·Phase: NA
-
Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to Aflibercept
NCT05610488 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy
NCT03006081 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema
NCT03927690 ·Status: COMPLETED ·Phase: PHASE2
-
Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema
NCT07295704 ·Status: RECRUITING
-
Comparison of Different Fluence Settings for Yellow Subthreshold Laser Treatment in Diabetic Macular Edema
NCT03571659 ·Status: COMPLETED
-
Intravitreal and Intracameral DEX in NPDR
NCT06951087 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Dexamethasone Intravitreal Implant in Retinal Vein Occlusion
NCT03559491 ·Status: COMPLETED
-
Navigation Laser Versus Traditional Laser Photocoagulation for Mild Diabetic Macular Edema
NCT03641144 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Intravitreal Triamcinolone Acetonide in Eyes With Post Vitrectomy Diabetic Vitreous Hemorrhage
NCT00300014 ·Status: UNKNOWN ·Phase: NA
-
Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema
NCT00886808 ·Status: COMPLETED ·Phase: PHASE1
-
Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy
NCT06599684 ·Status: COMPLETED ·Phase: PHASE2
-
Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection for Diabetic Macular Edema
NCT00764244 ·Status: COMPLETED ·Phase: PHASE3
-
Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes
NCT07270133 ·Status: NOT_YET_RECRUITING
-
Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema
NCT06881888 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME)
NCT03466099 ·Status: COMPLETED ·Phase: PHASE2
-
Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy
NCT04674254 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema
NCT00309192 ·Status: COMPLETED ·Phase: PHASE3
-
Outcomes After Vitrectomy in Eyes With Tractional Diabetic Macular Edema
NCT06316388 ·Status: NOT_YET_RECRUITING
-
A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)
NCT05066230 ·Status: TERMINATED ·Phase: PHASE3
-
Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation
NCT02995629 ·Status: COMPLETED ·Phase: NA